Development of Chimeric Antigen Receptor-Expressing iPSC-Derived Macrophages with Improved Anti-Tumor Activity

被引：3
|
作者：
Pouyanfard, Somayeh [1 ]
Fierro, Manuel [1 ]
Skaufman, Dan [1 ]
机构：
[1] Univ Calif San Diego, Div Regenerat Med, Dept Med, La Jolla, CA USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-148687
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1693
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Anti-tumor activity of RYZ101 (Ac-225 DOTATATE) in somatostatin receptor-expressing preclinical models of small-cell lung cancer
    Han, Guangzhou
    Hwang, Eunmi
    Lin, Fanching
    Clift, Renee
    Kim, Daniel
    Bischoff, Eric
    Moran, Susan
    Li, Gary
    CANCER RESEARCH, 2023, 83 (07)
  • [42] Leveraging CD16 fusion receptors to remodel the immune response for enhancing anti-tumor immunotherapy in iPSC-derived NK cells
    Meng, Fanyi
    Zhang, Siqi
    Xie, Juan
    Zhou, Yuan
    Wu, Qingling
    Lu, Binyan
    Zhou, Shixin
    Zhao, Xiangyu
    Li, Yang
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2023, 16 (01)
  • [43] Chimeric antigen receptor T cells targeting primary CNS lymphoma: Visualizing the anti-tumor response in vivo
    Mulazzani, Matthias
    Frassle, Simon
    Buchholz, Veit
    Straube, Andreas
    Busch, Dirk
    von Baumgarten, Louisa
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (03)
  • [44] Anti-Tumor Effects of Anti-CD20 Chimeric Antigen Receptor Therapy in Canine B Cell Lymphoma Patients
    Panjwani, M. Kazim
    Gnanandarajah, Josephine S.
    MaloneyHuss, Martha A.
    Mason, Nicola J.
    MOLECULAR THERAPY, 2016, 24 : S296 - S296
  • [45] CRISPR-Cas9 Knock out of CD5 Enhances the Anti-Tumor Activity of Chimeric Antigen Receptor T Cells
    Chun, Inkook
    Kim, Ki Hyun
    Chiang, Yi-Hao
    Xie, Wei
    Lee, Yong Gu Gu
    Pajarillo, Raymone
    Rotolo, Antonia
    Shestova, Olga
    Hong, Seok Jae
    Abdel-Mohsen, Mohamed
    Wysocka, Maria
    Ballard, Hatcher J.
    Barrett, David M.
    Posey, Avery D.
    Powell, Daniel, Jr.
    Gill, Saar I.
    Schuster, Stephen J.
    Barta, Stefan K.
    Rook, Alain H.
    June, Carl H.
    Ruella, Marco
    BLOOD, 2020, 136
  • [46] Targeting TGFβ with chimeric switch receptor and secreted trap to improve T cells anti-tumor activity
    Matikhina, Tatyana
    Cohen, Cyrille J.
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [47] Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma
    Brown, Christine E.
    Aguilar, Brenda
    Starr, Renate
    Yang, Xin
    Chang, Wen-Chung
    Weng, Lihong
    Chang, Brenda
    Sarkissian, Aniee
    Brito, Alfonso
    Sanchez, James F.
    Ostberg, Julie R.
    D'Apuzzo, Massimo
    Badie, Behnam
    Barish, Michael E.
    Forman, Stephen J.
    MOLECULAR THERAPY, 2018, 26 (01) : 31 - 44
  • [48] Manufacturing development and clinical production of NKG2D chimeric antigen receptor-expressing T cells for autologous adoptive cell therapy
    Murad, Joana M.
    Baumeister, Susanne H.
    Werner, Lillian
    Daley, Heather
    Trebeden-Negre, Helene
    Reder, Jake
    Sentman, Charles L.
    Gilham, David
    Lehmann, Frederic
    Snykers, Sarah
    Sentman, Marie-Louise
    Wade, Terri
    Schmucker, Adam
    Fanger, Michael W.
    Dranoff, Glenn
    Ritz, Jerome
    Nikiforow, Sarah
    CYTOTHERAPY, 2018, 20 (07) : 952 - 963
  • [49] CT-0508 is an anti-HER2 chimeric antigen receptor (CAR) macrophage with targeted anti-tumor activity that promotes a pro-inflammatory solid tumor microenvironment
    Klichinsky, Michael
    Gabrusiewicz, Konrad
    Anderson, Nicholas
    Schmierer, Maggie
    Best, Andrew
    Zeeman, Martha
    Chhum, Sotheavy
    Ohtani, Yumi
    Shestova, Olga
    Lu, Xueqing
    Petty, Nicholas
    Shan, Xinhe
    Shen, Feng
    Gill, Saar
    CANCER RESEARCH, 2020, 80 (16)
  • [50] Chimeric antigen receptor macrophages (CAR-M) induce anti-tumor immunity and synergize with T cell checkpoint inhibitors in pre-clinical solid tumor models.
    Pierini, Stefano
    Gabbasov, Rashid
    Gabitova, Linara
    Ohtani, Yumi
    Shestova, Olga
    Gill, Saar
    Abramson, Sascha
    Condamine, Thomas
    Klichinsky, Michael
    CANCER RESEARCH, 2021, 81 (13)
12345